Celsion Corp (NASDAQ:CLSN)
CAPS Rating:
A biotechnology company dedicated to furthering the development and commercialization of treatment systems for cancer and other diseases using focused heat energy in combination with other therapeutic devices or heat-activated genes.
RSS Headlines
Fool UK
Recs
will be in the low teens in two or three weeks then on to the mid 20's by April, 30's by end of 2013 and 40's sometime 2014
a huge mistake in investing is to try to make glorious predictions of price gain.......